Bdi Pharma Inc is categorized under Drugs, Proprietaries, and Sundries in Columbia, SC and active since 1995.
Bdi Pharma Inc was established in 1995, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Richard Gaton, President at the company’s single location by writing to 120 Research Drive, Columbia, South Carolina SC 29203 or by phoning (803) 732-1018. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bdi Pharma Inc |
| Contact Person: | Richard Gaton, President |
| Address: | 120 Research Drive, Columbia, South Carolina 29203 |
| Phone Number: | (803) 732-1018 |
| Website Address: | bdipharma.com |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 4242101 |
| Share This Business: |
Bdi Pharma Inc was started in 1995 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact Richard Gaton, President for inquiries that concern Bdi Pharma Inc by calling the company number (803) 732-1018, as your correspondence is most welcome. Additionally, the physical location of the single location of Bdi Pharma Inc can be found at the coordinates 34.10021,-80.96933 as well as the street address 120 Research Drive in Columbia, South Carolina 29203.
For its online presence, you may visit Bdi Pharma Inc’s website at bdipharma.com and engage with its social media outlets through on Twitter and on Facebook.